skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 5,219  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
BUPRENORPHINE HYDROCHLORIDE INJECTION
Material Type:
Article
Add to My Research

BUPRENORPHINE HYDROCHLORIDE INJECTION

Pharmacy times, 2020-07, Vol.86 (7), p.48

COPYRIGHT 2020 Pharmacy & Healthcare Communications, LLC ;ISSN: 0003-0627 ;EISSN: 2168-7234

Full text available

2
A Comparison of Buprenorphine, Sustained release Buprenorphine, and High concentration Buprenorphine in Male New Zealand White Rabbits
Material Type:
Article
Add to My Research

A Comparison of Buprenorphine, Sustained release Buprenorphine, and High concentration Buprenorphine in Male New Zealand White Rabbits

Journal of the American Association for Laboratory Animal Science, 2020-09, Vol.59 (5), p.546-556 [Peer Reviewed Journal]

American Association for Laboratory Animal Science 2020 ;ISSN: 1559-6109 ;EISSN: 2769-6677 ;DOI: 10.30802/AALAS-JAALAS-19-000132 ;PMID: 32674750

Full text available

3
No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir
Material Type:
Article
Add to My Research

No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir

Antimicrobial agents and chemotherapy, 2017-10, Vol.61 (10) [Peer Reviewed Journal]

Copyright © 2017 American Society for Microbiology. ;Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.00958-17 ;PMID: 28807904

Full text available

4
Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir
Material Type:
Article
Add to My Research

Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir

Clinical infectious diseases, 2012-02, Vol.54 (3), p.414-423 [Peer Reviewed Journal]

Copyright © 2012 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2012 ;2015 INIST-CNRS ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/cir799 ;PMID: 22100576 ;CODEN: CIDIEL

Full text available

5
Buprenorphine–Naloxone Therapy in Pain Management
Material Type:
Article
Add to My Research

Buprenorphine–Naloxone Therapy in Pain Management

Anesthesiology (Philadelphia), 2014-05, Vol.120 (5), p.1262-1274 [Peer Reviewed Journal]

2014 American Society of Anesthesiologists, Inc. ;2015 INIST-CNRS ;ISSN: 0003-3022 ;EISSN: 1528-1175 ;DOI: 10.1097/ALN.0000000000000170 ;PMID: 24509068 ;CODEN: ANESAV

Full text available

6
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
Material Type:
Article
Add to My Research

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder

Acta obstetricia et gynecologica Scandinavica, 2023-03, Vol.102 (3), p.313-322 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). ;2022 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). ;ISSN: 0001-6349 ;EISSN: 1600-0412 ;DOI: 10.1111/aogs.14497 ;PMID: 36562462

Full text available

7
Buprenorphine for managing opioid withdrawal
Material Type:
Article
Add to My Research

Buprenorphine for managing opioid withdrawal

Cochrane database of systematic reviews, 2017-02, Vol.2017 (2), p.CD002025 [Peer Reviewed Journal]

Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD002025.pub5 ;PMID: 28220474

Full text available

8
The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review
Material Type:
Article
Add to My Research

The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review

International journal of molecular sciences, 2018-08, Vol.19 (8), p.2410 [Peer Reviewed Journal]

2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 by the authors. 2018 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms19082410 ;PMID: 30111745

Full text available

9
Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option
Material Type:
Article
Add to My Research

Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option

Drugs (New York, N.Y.), 2018-08, Vol.78 (12), p.1211-1228 [Peer Reviewed Journal]

Springer Nature Switzerland AG 2018 ;Copyright Springer Nature B.V. Aug 2018 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-018-0953-z ;PMID: 30051169

Full text available

10
Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users
Material Type:
Article
Add to My Research

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

Addiction biology, 2015-07, Vol.20 (4), p.784-798 [Peer Reviewed Journal]

2014 Society for the Study of Addiction ;2014 Society for the Study of Addiction. ;2015 Society for the Study of Addiction ;ISSN: 1355-6215 ;EISSN: 1369-1600 ;DOI: 10.1111/adb.12163 ;PMID: 25060839

Full text available

11
Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial
Material Type:
Article
Add to My Research

Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial

The American journal of psychiatry, 2016-05, Vol.173 (5), p.491-498 [Peer Reviewed Journal]

Copyright © 2016 by the American Psychiatric Association 2016 ;Copyright American Psychiatric Publishing, Inc. May 1, 2016 ;ISSN: 0002-953X ;EISSN: 1535-7228 ;DOI: 10.1176/appi.ajp.2015.15040535 ;PMID: 26684923 ;CODEN: AJPSAO

Full text available

12
Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder
Material Type:
Article
Add to My Research

Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder

Annals of family medicine, 2017-07, Vol.15 (4), p.359-362 [Peer Reviewed Journal]

2017 Annals of Family Medicine, Inc. ;2017 Annals of Family Medicine, Inc. 2017 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.2099 ;PMID: 28694273

Full text available

13
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Material Type:
Article
Add to My Research

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

BMJ (Online), 2017-04, Vol.357, p.j1550-j1550 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2017 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.j1550 ;PMID: 28446428

Full text available

14
Opioids for cancer pain ‐ an overview of Cochrane reviews
Material Type:
Article
Add to My Research

Opioids for cancer pain ‐ an overview of Cochrane reviews

Cochrane database of systematic reviews, 2017-07, Vol.2020 (2), p.CD012592 [Peer Reviewed Journal]

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD012592.pub2 ;PMID: 28683172

Full text available

15
Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats
Material Type:
Article
Add to My Research

Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats

PloS one, 2017-04, Vol.12 (4), p.e0176443-e0176443 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Doodnaught et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Doodnaught et al 2017 Doodnaught et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0176443 ;PMID: 28445495

Full text available

16
Abuses of FDA Regulatory Procedures — The Case of Suboxone
Material Type:
Article
Add to My Research

Abuses of FDA Regulatory Procedures — The Case of Suboxone

The New England journal of medicine, 2020-02, Vol.382 (6), p.496-498 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1906680 ;PMID: 31914238

Full text available

17
Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs
Material Type:
Article
Add to My Research

Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs

Canadian journal of emergency medicine, 2023-10, Vol.25 (10), p.802-807 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Canadian Association of Emergency Physicians (CAEP)/ Association Canadienne de Médecine d'Urgence (ACMU) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2023. The Author(s), under exclusive licence to Canadian Association of Emergency Physicians (CAEP)/ Association Canadienne de Médecine d'Urgence (ACMU). ;ISSN: 1481-8035 ;EISSN: 1481-8043 ;DOI: 10.1007/s43678-023-00568-1 ;PMID: 37606738

Full text available

18
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
Material Type:
Article
Add to My Research

Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder

Neuropsychopharmacology (New York, N.Y.), 2024-05, Vol.49 (6), p.1050-1057 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 0893-133X ;EISSN: 1740-634X ;DOI: 10.1038/s41386-023-01793-z ;PMID: 38200140

Full text available

19
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
Material Type:
Article
Add to My Research

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial

Addiction (Abingdon, England), 2014-01, Vol.109 (1), p.79-87 [Peer Reviewed Journal]

2013 Society for the Study of Addiction ;2015 INIST-CNRS ;2013 Society for the Study of Addiction. ;2014 Society for the Study of Addiction ;ISSN: 0965-2140 ;EISSN: 1360-0443 ;DOI: 10.1111/add.12333 ;PMID: 23961726 ;CODEN: ADICE5

Full text available

20
Injection mensuelle de buprénorphine à libération prolongée
Material Type:
Article
Add to My Research

Injection mensuelle de buprénorphine à libération prolongée

Canadian Medical Association journal (CMAJ), 2023-03, Vol.195 (12), p.E462-E463 [Peer Reviewed Journal]

COPYRIGHT 2023 CMA Impact Inc. ;2023 CMA Impact Inc. or its licensors 2023 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.220730-f

Full text available

Results 1 - 20 of 5,219  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (4,252)

Refine My Results

Creation Date 

From To
  1. Before 1985  (99)
  2. 1985 To 1993  (276)
  3. 1994 To 2002  (455)
  4. 2003 To 2012  (1,413)
  5. After 2012  (2,976)
  6. More options open sub menu

Language 

  1. English  (5,016)
  2. Japanese  (168)
  3. French  (87)
  4. Norwegian  (54)
  5. German  (38)
  6. Portuguese  (20)
  7. Swedish  (20)
  8. Spanish  (17)
  9. Korean  (12)
  10. BokmÃ¥l, Norwegian  (7)
  11. Persian  (6)
  12. Turkish  (4)
  13. Italian  (3)
  14. Chinese  (3)
  15. Danish  (3)
  16. Serbian  (1)
  17. Czech  (1)
  18. Latvian  (1)
  19. Russian  (1)
  20. Polish  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait